Ketek and Yasmin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ketek (telithromycin) and Yasmin (drospirenone; ethinyl estradiol). Common drug interactions include pain among females and cholecystitis chronic among males.

The phase IV clinical study analyzes what interactions people have when they take Ketek and Yasmin. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Ketek?

Ketek has active ingredients of telithromycin. eHealthMe is studying from 4,631 Ketek users. Check the latest studies of Ketek.

What is Yasmin?

Yasmin has active ingredients of drospirenone; ethinyl estradiol. It is often used in birth control. eHealthMe is studying from 48,855 Yasmin users. Check the latest studies of Yasmin.



On Jul, 18, 2026

24 people who take Ketek and Yasmin together, and have interactions are studied.

Ketek and Yasmin drug interactions.

What are the common drug interactions of Ketek and Yasmin, by gender? *:

female:

  1. Pain
  2. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  3. Injury
  4. Pulmonary embolism (blockage of the main artery of the lung)
  5. Nausea (feeling of having an urge to vomit)
  6. Hepatitis (inflammation of the liver)
  7. Vision blurred
  8. Asthenia (weakness)
  9. Decreased appetite
  10. Fatigue (feeling of tiredness)

male:

  1. Cholecystitis chronic (long lasting infection of gallbladder)
  2. Abdominal discomfort
  3. Premenstrual syndrome
  4. Vitamin b12 decreased
  5. Abdominal pain upper
  6. Axillary vein thrombosis (formation of a blood clot in axillary vein)
  7. Cholesterosis (abnormal deposition of cholesterol in tissues)
  8. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  9. Drug ineffective
  10. Impaired healing

What are the common drug interactions of Ketek and Yasmin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Abdominal discomfort
  2. Cholecystitis chronic (long lasting infection of gallbladder)
  3. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  4. Depression
  5. Diarrhoea
  6. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures)
  7. Fatigue (feeling of tiredness)
  8. Gallbladder injury
  9. Irritability
  10. Premenstrual dysphoric disorder

10-19:

n/a

20-29:

  1. Pain
  2. Biliary dyskinesia (motility disorder that affects the gallbladder and sphincter of oddi)
  3. Gallbladder disorder
  4. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  5. Injury
  6. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  7. Diplopia (double vision)
  8. Dizziness
  9. Foetal distress syndrome (altered heart rate or rhythm and leading tocompromised blood flow or changes in blood chemistry of foetus)
  10. Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)

30-39:

  1. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  2. Pulmonary embolism (blockage of the main artery of the lung)
  3. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  4. Injury
  5. Pain
  6. Abdominal pain upper
  7. Cholecystitis chronic (long lasting infection of gallbladder)
  8. Cholesterosis (abnormal deposition of cholesterol in tissues)
  9. Nausea (feeling of having an urge to vomit)
  10. Pancreatitis (inflammation of pancreas)

40-49:

  1. Nausea (feeling of having an urge to vomit)
  2. Vomiting
  3. Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
  4. Lethargy (tiredness)
  5. Myopia (difficult to see objects that are far away)
  6. Nuchal rigidity (a resistance to flexion of the neck)
  7. Photophobia (extreme sensitivity to light)
  8. Presbyopia (a condition in which the lens of the eye loses its ability to focus, making it difficult to see objects up close)
  9. Pyrexia (fever)
  10. Somnolence (a state of near-sleep, a strong desire for sleep)

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

  1. Sinusitis (inflammation of sinus): 4 people, 16.67%
  2. Menstruation Irregular: 3 people, 12.50%
  3. Premenstrual Syndrome: 2 people, 8.33%
  4. Muscle Spasms (muscle contraction): 2 people, 8.33%
  5. Infection: 2 people, 8.33%
  6. Depression: 2 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Ketek and Yasmin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ketek and Yasmin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ketek:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Yasmin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ketek and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Yasmin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on telithromycin and drospirenone; ethinyl estradiol (the active ingredients of Ketek and Yasmin, respectively), and Ketek and Yasmin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: